The stock of Inspire Medical Systems Inc (INSP) has seen a 30.40% increase in the past week, with a 39.93% gain in the past month, and a -25.12% decrease in the past quarter. The volatility ratio for the week is 6.83%, and the volatility levels for the past 30 days are at 5.57% for INSP. The simple moving average for the past 20 days is 31.32% for INSP’s stock, with a 3.63% simple moving average for the past 200 days.
Is It Worth Investing in Inspire Medical Systems Inc (NYSE: INSP) Right Now?
The price-to-earnings ratio for Inspire Medical Systems Inc (NYSE: INSP) is 1012.24x, which is above its average ratio. Moreover, the 36-month beta value for INSP is 1.28. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 3 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for INSP is 29.08M and currently, short sellers hold a 4.97% of that float. On August 07, 2024, INSP’s average trading volume was 708.39K shares.
INSP) stock’s latest price update
Inspire Medical Systems Inc (NYSE: INSP)’s stock price has plunge by 25.11relation to previous closing price of 147.01. Nevertheless, the company has seen a 30.40% surge in its stock price over the last five trading sessions. seekingalpha.com reported 2024-08-06 that Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript
Analysts’ Opinion of INSP
Many brokerage firms have already submitted their reports for INSP stocks, with BofA Securities repeating the rating for INSP by listing it as a “Neutral.” The predicted price for INSP in the upcoming period, according to BofA Securities is $225 based on the research report published on May 08, 2024 of the current year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see INSP reach a price target of $285. The rating they have provided for INSP stocks is “Outperform” according to the report published on April 19th, 2024.
Morgan Stanley gave a rating of “Overweight” to INSP, setting the target price at $250 in the report published on March 19th of the current year.
INSP Trading at 25.37% from the 50-Day Moving Average
After a stumble in the market that brought INSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.81% of loss for the given period.
Volatility was left at 5.57%, however, over the last 30 days, the volatility rate increased by 6.83%, as shares surge +40.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.95% upper at present.
During the last 5 trading sessions, INSP rose by +30.48%, which changed the moving average for the period of 200-days by +17.18% in comparison to the 20-day moving average, which settled at $142.69. In addition, Inspire Medical Systems Inc saw -9.59% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSP starting from Griffin Jerry C, who proposed sale 5,952 shares at the price of $126.53 back on Jul 26 ’24. After this action, Griffin Jerry C now owns shares of Inspire Medical Systems Inc, valued at $753,086 using the latest closing price.
Buchholz Richard, the Chief Financial Officer of Inspire Medical Systems Inc, sale 15,000 shares at $230.03 during a trade that took place back on Apr 17 ’24, which means that Buchholz Richard is holding 28,271 shares at $3,450,450 based on the most recent closing price.
Stock Fundamentals for INSP
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.85 for the gross margin
The net margin for Inspire Medical Systems Inc stands at 0.01. The total capital return value is set at -0.02. Equity return is now at value 1.03, with 0.89 for asset returns.
Based on Inspire Medical Systems Inc (INSP), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 1.42. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -3.33.
Currently, EBITDA for the company is -40.27 million with net debt to EBITDA at 114.91. When we switch over and look at the enterprise to sales, we see a ratio of 7.56. The receivables turnover for the company is 8.85for trailing twelve months and the total asset turnover is 0.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.25.
Conclusion
To wrap up, the performance of Inspire Medical Systems Inc (INSP) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
